Evidence map›Paper›PMID 31281443›Full record

ArticleExperimental and therapeutic medicine2019

Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination.

Ayman Mohamed, Ghada Al-Kafaji, Amal Almahroos, Zahra Almosawi, Hawra Alalwan, Reem Abdulla, Fajer Alammadi, Ahmed Almubarak, Ahmed Al-Mahrezi, Amer Kamal

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ayman MohamedDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Ghada Al-KafajiDepartment of Molecular Medicine and Al-Jawhara Centre for Molecular Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Amal AlmahroosDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Zahra AlmosawiDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Hawra AlalwanDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Reem AbdullaDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Fajer AlammadiDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Ahmed AlmubarakDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Ahmed Al-MahreziDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Amer KamalDepartment of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain.
Arabian Gulf University · BH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impairment in cognition and motor activity are commonly encountered in patients affected by multiple sclerosis (MS), and depression is believed to be a contributing factor. The aim of the present study was to investigate the impact of induced depression on a cuprizone mouse model of demyelination and the effectiveness of enhanced environment (EE) as a method of intervention. C57BL/6 male mice were divided into five groups: Cuprizone only (Cup-O), cuprizone undergoing depression (Cup-Dep), cuprizone housed in EE (Cup-EE), cuprizone housed in EE and undergoing depression (Cup-ED) and the control (n=9-10 per group). Depression was induced by repeated open-space forced swim. Neurobehavioral tests were conducted following a 6-week period of 0.2% cuprizone-enriched diet. The Cup-EE group performed significantly better in terms of cognition and motor functions, when compared with the Cup-O group, as evidenced by the Morris water maze (MWM; P<0.001) and rotarod performance test (P<0.05) results. Conversely, the Cup-Dep group exhibited a significant decline in performance in the MWM (P<0.001) and rotarod performance test (P<0.05), when compared with the Cup-O group. The Cup-ED group had comparable results to those of the Cup-O group, indicating a reversal of the induced depression effects. Open field test results failed to show an anxiety-like behavior in the cuprizone mouse model. It was therefore concluded that EE can improve MS-associated cognitive and motor deficits. Insights gained from these results facilitate the exploration of non-medical modes of intervention as an emerging adjuvant therapy in MS.

Indexed as

anxietycuprizonedemyelinationdepressionenvironment enhancementmotor coordinationmultiple sclerosiswater maze

Identifiers

PMID31281443
PMCPMC6591500
OpenAlexW2952102008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.